| Summary: | <p>Abstract</p> <p>Background</p> <p>Latent membrane protein (LMP) 1 and LMP2A encoded by Epstein-Barr virus (EBV) are associated with the development of malignancies, but their expression in extranodal NK/T-cell lymphoma, nasal type (ENKTL) and the relationship with clinical characteristics of this disease remain poorly understood. In the present study, we examined the expression of LMP1 and LMP2A in ENKTL, and investigated the correlations between LMP1 and LMP2A expression with clinicopathological characteristics of ENKTL patients.</p> <p>Methods</p> <p>Paraffin sections of surgically removed samples from 16 ENKTL patients were analyzed by immunohistochemistry and the related clinicopathological data were collected and analyzed.</p> <p>Results</p> <p>Elevated expression (immunohistochemistry score ≥ 4) of LMP1 and LMP2A was detected in the tumor cells of ENKTL. High LMP1 expression was associated with positive B symptoms (p = 0.012), while high LMP2A expression was related to gender (p = 0.029). The expression of both LMP1 and LMP2A showed significant correlations with patients’ overall survival (p = 0.049, p = 0.036).</p> <p>Conclusion</p> <p>LMP1 and LMP2A may be prognostic indicators of survival in patients with ENKTL.</p> <p>Virtual slides</p> <p><url>http://www.diagnosticpathology.diagnomx.eu/vs/2443352538545899</url></p>
|
|---|
